Insider Buying: Precipio, Inc. (NASDAQ:PRPO) Director Purchases 8,035 Shares of Stock

Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg purchased 8,035 shares at an average price of $9.27, totaling $74,484.45, increasing his ownership by 26.66% to 38,175 shares valued at approximately $353,882.25. The acquisition was disclosed to the SEC. PRPO stock opened at $9.65, down 2.5%, with a market cap of $14.59 million. The company reported a quarterly loss of ($0.59) per share and revenue of $4.93 million. Renaissance Technologies LLC recently acquired 10,100 shares, owning about 0.68% of the company.

Precipio, Inc. (NASDAQ:PRPO - Get Free Report) Director Richard A. Sandberg bought 8,035 shares of the business's stock in a transaction dated Wednesday, May 21st. The stock was acquired at an average price of $9.27 per share, for a total transaction of $74,484.45. Following the purchase, the director now directly owns 38,175 shares in the company, valued at approximately $353,882.25. The trade was a 26.66% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Precipio Stock Down 2.5%

PRPO stock opened at $9.65 on Friday. The stock has a market cap of $14.59 million, a P/E ratio of -5.27 and a beta of 1.12. The company has a current ratio of 0.73, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02. The stock's fifty day simple moving average is $6.41 and its two-hundred day simple moving average is $6.44. Precipio, Inc. has a 1-year low of $3.90 and a 1-year high of $10.74.

Precipio (NASDAQ:PRPO - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The biotechnology company reported ($0.59) earnings per share for the quarter. Precipio had a negative net margin of 17.23% and a negative return on equity of 34.01%. The company had revenue of $4.93 million for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Precipio stock. Renaissance Technologies LLC acquired a new stake in Precipio, Inc. (NASDAQ:PRPO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 10,100 shares of the biotechnology company's stock, valued at approximately $56,000. Renaissance Technologies LLC owned about 0.68% of Precipio at the end of the most recent quarter. 10.45% of the stock is currently owned by hedge funds and other institutional investors.

About Precipio

(Get Free Report)

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.